Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypercholesterolemia: HELP
Christie M. Ballantyne
Based on 29 articles published since 2008
||||
Expertise Level
The expertise of Christie M. Ballantyne ranks in the
  • Top 0.018%
  • ... of 27,988 published authors worldwide on Hypercholesterolemia
  • ... from 2008 through 2018
  • ... based on contributions to 29 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Ballantyne, Christie   ·   Ballantyne, Christie M
Work Locations
Details
Most likely:    Baylor College of Medicine   Contact    
2017
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Merck & Co., Inc., Kenilworth, New Jersey. · Kocaeli University Medical Faculty, Kocaeli, Turkey. · China PLA General Hospital, Beijing, China. · The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. · Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. · Asan Medical Center, Seoul, South Korea. · Nucleo de Pesquisa Clinica, Parana, Brazil. · State Budgetary Healthcare Institution, Moscow, Russia. · Cardioarritmias e Investigacion SC, San Luis Potosi S.L.P., Mexico. · Pubmed 28624096
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
  • Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: · Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey. · Pubmed 27956003
2016
  • Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27663902
  • Department of Cardiology, Hartford Hospital, Hartford, CT, USA. Electronic address: · Esperion Therapeutics Inc., Ann Arbor, MI, USA. · Medpace Inc., Cincinnati, OH, USA. · School of Pharmacy, Virginia Commonwealth University and National Clinical Research Inc., Richmond, VA, USA. · Baylor College of Medicine and Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27206943
  • Department of Medicine, Baylor College of Medicine and Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Virginia Commonwealth University and National Clinical Research Inc., Richmond, Virginia. · Clinical Development, Esperion Therapeutics, Inc., Ann Arbor, Michigan. · Research and Development, Esperion Therapeutics, Inc., Ann Arbor, Michigan. · Pubmed 27138185
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
  • Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Department of Psychology, University of Houston, Houston, TX, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations, Houston, TX, USA. · Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA. · Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL, USA. · Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA. Electronic address: · Pubmed 26773472
2015
  • Section of Cardiovascular Research, Division of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Research, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Orange County Research Center, Tustin, California. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Statistics, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. · Pubmed 25784512
  • Clinical Research of South Florida, Coral Gables, FL, USA. · Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Pubmed 26336957
2014
  • Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. Electronic address: · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · AstraZeneca, Wilmington, DE, USA. · Keele University, Keele, UK. · AstraZeneca R&D Mölndal, Mölndal, Sweden; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. · Pubmed 24401221
2013
  • Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Pubmed 23770179
  • Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. · Pubmed 23237107
2008
  • Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. · Pubmed 18471454
2015
  • From the Department of Medicine (L.X., X.D.P., J.L.P., D.Y., C.M.B., H.W.) and Department of Pediatrics (C.M.B., H.W.), Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital and Baylor College of Medicine, TX (C.M.B.); Research Center for Human Genetics, Institute of Molecular Medicine, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston (B.-B.T.); Department of Biomedical Engineering, University of California, Davis (S.I.S.); and Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (L.X., X.X.). · From the Department of Medicine (L.X., X.D.P., J.L.P., D.Y., C.M.B., H.W.) and Department of Pediatrics (C.M.B., H.W.), Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital and Baylor College of Medicine, TX (C.M.B.); Research Center for Human Genetics, Institute of Molecular Medicine, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston (B.-B.T.); Department of Biomedical Engineering, University of California, Davis (S.I.S.); and Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (L.X., X.X.). · Pubmed 26112011
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2011
  • Health Policy and Quality Program, Michael E. DeBakey VA Medical Center, Health Services Research and Development Center of Excellence and Section of Health Services Research, Baylor College of Medicine, Houston, TX 77030, USA. · Pubmed 21854896
2009
  • Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Pubmed 19433759
Probable:    Miscellaneous institutions in Houston      
2017
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
2016
  • Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27663902
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 29 total) written by Christie M. Ballantyne about Hypercholesterolemia:

  • 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. 2017
  • A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. 2017
  • Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. 2017
  • Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol. 2017
  • Bempedoic Acid (ETC-1002): an Investigational Inhibitor of ATP Citrate Lyase. 2016
  • Treatment with ETC-1002 alone and in combination with ezetimibe lowers LDL cholesterol in hypercholesterolemic patients with or without statin intolerance. 2016
  • Effect of ETC-1002 on Serum Low-Density Lipoprotein Cholesterol in Hypercholesterolemic Patients Receiving Statin Therapy. 2016
  • Comparison of PCSK9 Inhibitor Evolocumab vs Ezetimibe in Statin-Intolerant Patients: Design of the Goal Achievement After Utilizing an Anti-PCSK9 Antibody in Statin-Intolerant Subjects 3 (GAUSS-3) Trial. 2016
  • Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial. 2016
  • Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. 2016
Show List of Full Article Records
Google Searches

Learn more about Christie M. Ballantyne using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Baylor College of Medicine
Miscellaneous institutions in Houston
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Baylor College of Medicine
2017
  • Baylor College of Medicine, Houston, Texas. Electronic address: · Merck & Co., Inc., Kenilworth, New Jersey. · Kocaeli University Medical Faculty, Kocaeli, Turkey. · China PLA General Hospital, Beijing, China. · The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China. · Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan. · Asan Medical Center, Seoul, South Korea. · Nucleo de Pesquisa Clinica, Parana, Brazil. · State Budgetary Healthcare Institution, Moscow, Russia. · Cardioarritmias e Investigacion SC, San Luis Potosi S.L.P., Mexico. · Pubmed 28624096
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
  • Section of Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: · Merck Research Laboratories, Global Clinical Development, Cardiovascular Disease, Kenilworth, New Jersey. · Pubmed 27956003
2016
  • Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27663902
  • Department of Cardiology, Hartford Hospital, Hartford, CT, USA. Electronic address: · Esperion Therapeutics Inc., Ann Arbor, MI, USA. · Medpace Inc., Cincinnati, OH, USA. · School of Pharmacy, Virginia Commonwealth University and National Clinical Research Inc., Richmond, VA, USA. · Baylor College of Medicine and Houston Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27206943
  • Department of Medicine, Baylor College of Medicine and Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Virginia Commonwealth University and National Clinical Research Inc., Richmond, Virginia. · Clinical Development, Esperion Therapeutics, Inc., Ann Arbor, Michigan. · Research and Development, Esperion Therapeutics, Inc., Ann Arbor, Michigan. · Pubmed 27138185
  • Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio. · Department of Clinical Development, and Biostatistics, Amgen Inc., Thousand Oaks, California. · The Cardiometabolic Disorders Unit, Mount Sinai Heart, Icahn School of Medicine at Mount Sinai, New York, New York. · Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands. · Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit and Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · Department of Medicine, Division of Cardiology, University of British Columbia, Vancouver, British Columbia, Canada. · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Department of Pharmacological Sciences, University of Milan, and IRCCS Multimedica, Milan, Italy. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Department of Cardiology, Hartford Hospital, Hartford, Connecticut. · Pubmed 26946077
  • Cleveland Clinic, Cleveland, Ohio. · University of Amsterdam Faculty of Medicine, Amsterdam, the Netherlands. · Amgen Inc, Thousand Oaks, California. · School of Medicine at Mount Sinai, New York, New York. · Flinders University, Bedford Park, SA, Australia. · University of Glasgow, Glasgow, United Kingdom. · Clinical Trial Service Unit, University of Oxford, Oxford, United Kingdom8Epidemiological Services Unit, University of Oxford, Oxford, United Kingdom. · University Hospital of Paris 6, Paris, France. · Charles University in Prague, Prague, Czech Republic11General University Hospital in Prague, Prague, Czech Republic. · David Geffen School of Medicine at the University of California, Los Angeles. · Baylor College of Medicine, Houston, Texas. · Center for Endocrinology, Diabetes and Preventive Medicine, University of Cologne, Cologne, Germany. · Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio. · Pubmed 27039291
  • Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Department of Psychology, University of Houston, Houston, TX, USA. · Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations, Houston, TX, USA. · Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA. · Center for Prevention and Wellness Research, Baptist Health Medical Group, Miami Beach, FL, USA. · Sections of Cardiovascular Research, Baylor College of Medicine, Houston, TX, USA; Department of Medicine, Baylor College of Medicine, Houston, TX, USA; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA; Health Policy, Quality & Informatics Program, Michael E. DeBakey VA Medical Center Health Services Research & Development Center for Innovations, Houston, TX, USA; Michael E. DeBakey VA Medical Center, Houston, TX, USA. Electronic address: · Pubmed 26773472
2015
  • Section of Cardiovascular Research, Division of Atherosclerosis, Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Research, Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Orange County Research Center, Tustin, California. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Statistics, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Clinical Pharmacology, Global Innovative Pharma Business, Pfizer Inc., Groton, Connecticut. · Clinical Sciences, Global Innovative Pharma Business, Pfizer Inc., New York, New York. · Louisville Metabolic and Atherosclerosis Research Center, Louisville, Kentucky. · Pubmed 25784512
  • Clinical Research of South Florida, Coral Gables, FL, USA. · Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Wexner Medical Center, The Ohio State University, Columbus, Ohio, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Merck & Co., Inc., Kenilworth, NJ, USA. · Pubmed 26336957
2014
  • Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. Electronic address: · Department of Medicine, Baylor College of Medicine and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · AstraZeneca, Wilmington, DE, USA. · Keele University, Keele, UK. · AstraZeneca R&D Mölndal, Mölndal, Sweden; Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Sweden. · Pubmed 24401221
2013
  • Department of Medicine, Baylor College of Medicine, Houston, Texas; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas. Electronic address: · Pubmed 23770179
  • Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. · Pubmed 23237107
2008
  • Baylor College of Medicine and Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA. · Pubmed 18471454
2015
  • From the Department of Medicine (L.X., X.D.P., J.L.P., D.Y., C.M.B., H.W.) and Department of Pediatrics (C.M.B., H.W.), Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital and Baylor College of Medicine, TX (C.M.B.); Research Center for Human Genetics, Institute of Molecular Medicine, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston (B.-B.T.); Department of Biomedical Engineering, University of California, Davis (S.I.S.); and Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (L.X., X.X.). · From the Department of Medicine (L.X., X.D.P., J.L.P., D.Y., C.M.B., H.W.) and Department of Pediatrics (C.M.B., H.W.), Baylor College of Medicine, Houston, TX; Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston Methodist Hospital and Baylor College of Medicine, TX (C.M.B.); Research Center for Human Genetics, Institute of Molecular Medicine, Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston (B.-B.T.); Department of Biomedical Engineering, University of California, Davis (S.I.S.); and Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (L.X., X.X.). · Pubmed 26112011
  • From the Thrombolysis in Myocardial Infarction (TIMI) Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital, and the Department of Medicine, Harvard Medical School, Boston (M.S.S., R.P.G., S.D.W.); the Carbohydrate and Lipid Metabolism Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg (F.J.R.), and the Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town (D.J.B.) - both in South Africa; the Departments of Epidemiology and Medicine, College of Public Health, University of Iowa, Iowa City (J.R.); the Sections of Cardiovascular Research and Cardiology, Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Houston Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.); Amgen, Thousand Oaks, CA (R. Somaratne, J.L., S.M.W., R. Scott); Jacksonville Center for Clinical Research, Jacksonville, FL (M.J.K.); and the Metabolic and Atherosclerosis Research Center, Cincinnati (E.A.S.). · Pubmed 25773607
2011
  • Health Policy and Quality Program, Michael E. DeBakey VA Medical Center, Health Services Research and Development Center of Excellence and Section of Health Services Research, Baylor College of Medicine, Houston, TX 77030, USA. · Pubmed 21854896
2009
  • Section of Atherosclerosis and Vascular Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. · Pubmed 19433759
Miscellaneous institutions in Houston
2017
  • Division of Lipidology, Department of Medicine, University of Cape Town, Cape Town, South Africa. · Jacksonville Center for Clinical Research, Jacksonville, Florida. · Sterling Research Group, Cincinnati, Ohio. · Amgen Inc., Thousand Oaks, California. · Gilead Sciences, Fremont, California. · Ionis Pharmaceuticals, San Diego, California. · Amgen Limited, Cambridge, UK. · Baylor College of Medicine, Houston, Texas. · Houston Methodist DeBakey Heart and Vascular Center, Houston, Texas. · Diabetes Trials Unit, OCDEM, University of Oxford, Oxford, UK. · Pubmed 27619750
2016
  • Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Cardiovascular Research, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Cardiology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA. · Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA. · Pubmed 27663902
17 Other Locations Show
Yearly article counts 04642225031
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.